NCT01394510View on ClinicalTrials.gov

Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2015

Conditions
Type 2 DiabetesOxidative Stress
Interventions
DRUG

N-acetylcysteine

600 mg N-acetylcysteine (NAC) twice daily by mouth for 2 weeks followed by 1200 mg NAC twice daily by mouth for 2 additional weeks.

Trial Locations (1)

98108

VA Puget Sound Health Care System, Seattle

All Listed Sponsors
collaborator

VA Puget Sound Health Care System

FED

lead

Utzschneider, Kristina, M.D.

INDIV

NCT01394510 - Effect of the Anti-oxidant N-acetylcysteine on Beta-cell Function in Type 2 Diabetes | Biotech Hunter | Biotech Hunter